Most Liquid Health Care Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1GEHC GE HealthCare Technologies
1.84 B
 0.04 
 1.74 
 0.07 
2RVTY Revvity
1.22 B
(0.03)
 1.96 
(0.05)
3RVMDW Revolution Medicines, Warrant
298.84 M
(0.01)
 19.65 
(0.23)
4IRON Disc Medicine
184.07 M
(0.08)
 2.20 
(0.18)
5IMTXW immatics biotechnologies GmbH
178.39 M
(0.11)
 23.73 
(2.59)
6GRAL GRAIL, LLC
177.56 M
 0.15 
 9.62 
 1.49 
7BKDT Brookdale Senior Living
171.27 M
 0.07 
 2.33 
 0.17 
8TRML Tourmaline Bio
169.93 M
(0.30)
 3.52 
(1.06)
9RCKTW Rocket Pharmaceuticals, Warrant
143.36 M
 0.16 
 14.88 
 2.38 
10LENZ LENZ Therapeutics
138.69 M
(0.21)
 3.77 
(0.80)
11MGX Metagenomi, Common Stock
133.59 M
 0.05 
 17.65 
 0.95 
12BRNS Barinthus Biotherapeutics plc
133.15 M
 0.03 
 5.59 
 0.15 
13WGSWW GeneDx Holdings Corp
130.8 M
 0.13 
 12.31 
 1.60 
14HUMAW Humacyte
127.9 M
(0.07)
 8.65 
(0.59)
15ZURA Zura Bio Limited
120.52 M
(0.22)
 5.92 
(1.32)
16KRRO Frequency Therapeutics
120.47 M
(0.17)
 4.96 
(0.87)
17FTRE Fortrea Holdings
119.27 M
(0.26)
 4.55 
(1.18)
18TALKW Talkspace
112.99 M
 0.01 
 10.33 
 0.12 
19APGE Apogee Therapeutics, Common
109.87 M
(0.15)
 4.24 
(0.65)
20LXEO Lexeo Therapeutics, Common
100.11 M
(0.29)
 5.88 
(1.69)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).